Chendi Zhan

498 total citations
12 papers, 431 citations indexed

About

Chendi Zhan is a scholar working on Molecular Biology, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Chendi Zhan has authored 12 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Physiology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Chendi Zhan's work include Alzheimer's disease research and treatments (7 papers), Protein Structure and Dynamics (3 papers) and Autophagy in Disease and Therapy (2 papers). Chendi Zhan is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Protein Structure and Dynamics (3 papers) and Autophagy in Disease and Therapy (2 papers). Chendi Zhan collaborates with scholars based in China, Israel and United States. Chendi Zhan's co-authors include Guanghong Wei, Yiming Tang, Yujie Chen, Xuewei Dong, Zenghui Lao, Lihi Adler‐Abramovich, Jiangtao Lei, Linda J. W. Shimon, Ehud Gazit and Xuhua Li and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Nano and Chemical Communications.

In The Last Decade

Chendi Zhan

12 papers receiving 429 citations

Peers

Countries citing papers authored by Chendi Zhan

Since Specialization

Citations

This map shows the geographic impact of Chendi Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chendi Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chendi Zhan more than expected).

Fields of papers citing papers by Chendi Zhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chendi Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chendi Zhan. The network helps show where Chendi Zhan may publish in the future.

Co-authorship network of co-authors of Chendi Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Chendi Zhan. A scholar is included among the top collaborators of Chendi Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chendi Zhan. Chendi Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Five similar anthocyanidin molecules display distinct disruptive effects and mechanisms of action on Aβ1–42 protofibril: A molecular dynamic simulation study 2023 ·International Journal of Biological Macromolecules ·Yujie Chen, Chendi Zhan, Xuhua Li, (unknown), Yifei Yao, (unknown), Guanghong Wei	9
2	Dissecting the Inhibitory Mechanism of the αB-Crystallin Domain against Aβ₄₂ Aggregation and Its Effect on Aβ₄₂ Protofibrils: A Molecular Dynamics Simulation Study 2022 ·ACS Chemical Neuroscience ·(unknown), (unknown), Yu Zou, (unknown), (unknown), Chendi Zhan, Guanghong Wei, Qingwen Zhang	10
3	A Comprehensive Insight into the Mechanisms of Dopamine in Disrupting Aβ Protofibrils and Inhibiting Aβ Aggregation 2021 ·ACS Chemical Neuroscience ·Yujie Chen, Xuhua Li, Chendi Zhan, Zenghui Lao, (unknown), Xuewei Dong, Guanghong Wei	46
4	Serotonin and Melatonin Show Different Modes of Action on Aβ₄₂ Protofibril Destabilization 2021 ·ACS Chemical Neuroscience ·(unknown), Chendi Zhan, Yu Zou, Zhenyu Qian, Guanghong Wei, Qingwen Zhang	36
5	Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ₄₂ aggregation and disruption of Aβ₄₂ protofibril: similarities and differences 2021 ·Physical Chemistry Chemical Physics ·(unknown), Chendi Zhan, Xuewei Dong, Guanghong Wei	44
6	Natural stereoisomeric flavonoids exhibit different disruptive effects and the mechanism of action on Aβ₄₂ protofibril 2021 ·Chemical Communications ·Chendi Zhan, Zenghui Lao, Yiming Tang, Qin Qiao, Guanghong Wei	31
7	Green tea extract EGCG plays a dual role in Aβ42 protofibril disruption and membrane protection: A molecular dynamic study 2020 ·Chemistry and Physics of Lipids ·Xuewei Dong, Yiming Tang, Chendi Zhan, Guanghong Wei	30
8	Green Tea Extracts EGCG and EGC Display Distinct Mechanisms in Disrupting Aβ₄₂ Protofibril 2020 ·ACS Chemical Neuroscience ·Chendi Zhan, Yujie Chen, Yiming Tang, Guanghong Wei	95
9	Structural Polymorphism in a Self-Assembled Tri-Aromatic Peptide System 2018 ·ACS Nano ·(unknown), Jiangtao Lei, Chendi Zhan, Linda J. W. Shimon, Lihi Adler‐Abramovich, Guanghong Wei, Ehud Gazit	92
10	Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9 2016 ·Angewandte Chemie ·William M. Hewitt, G.T. Lountos, (unknown), Samuel D. Dahlhauser, Lindsey B. Saunders, D. Needle, Joseph E. Tropea, Chendi Zhan, Guanghong Wei, Buyong Ma, Ruth Nussinov, David S. Waugh, John S. Schneekloth	1
11	Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9 2016 ·Angewandte Chemie International Edition ·William M. Hewitt, G.T. Lountos, (unknown), Samuel D. Dahlhauser, Lindsey B. Saunders, D. Needle, Joseph E. Tropea, Chendi Zhan, Guanghong Wei, Buyong Ma, Ruth Nussinov, David S. Waugh, John S. Schneekloth	16
12	Conformational dynamics of cancer-associated MyD88-TIR domain mutant L252P (L265P) allosterically tilts the landscape toward homo-dimerization 2016 ·Protein Engineering Design and Selection ·Chendi Zhan, Ruxi Qi, Guanghong Wei, Emine Guven‐Maiorov, Ruth Nussinov, Buyong Ma	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact